Ben S Gold, PhD

Highlights

1
ACS infectious diseases · 2022
BSBen S Gold CFCarl F. Nathan
PMID: 35192346PMCID: PMC8922279DOIFirst author22 citations
2
Methods in molecular biology (Clifton, N.J.) · 2021
BSBen S Gold CFCarl F. Nathan
PMID: 34235673DOIFirst author12 citations

43

3 grants

Co-I
Evaluation of hits and leads for TBDA priority targets - INV100447
Bill & Melinda Gates Foundation · 2026–2027
INV-100447
PI
Evaluation of NadD and NadE hits and leads for TB - INV-083642
Bill & Melinda Gates Foundation · 2025–2026
BMGF INV-083642
PI
Identification of NadD and NadE hits and leads for TB
Bill & Melinda Gates Foundation · 2024–2026
INV-070007

Completed grants (5)

MPI
Screening NadE and NadD
Bill & Melinda Gates Foundation · 2022–2024
BMGF INV-047552
Co-I
Phosphopantetheinyl transferase (PptT) inhibitors for treatment of TB- INV-040480
Bill & Melinda Gates Foundation · 2022–2024
INV-040480
PI
Role of NadD in Mycobacterium tuberculosis proteostasis
National Institute of Allergy and Infectious Diseases · 2021–2024
R21AI159572-02
Co-I
Phosphopantetheinyl Transferase (PptT) Inhibitors for Treatment of Tuberculosis
Bill & Melinda Gates Foundation · 2018–2022
OPP1190511
Co-I
Tri-Institutional TB Research Unit: Persistence and Latency - Diversity Supplement
National Institute of Allergy and Infectious Diseases · 2014–2021· 2 renewals
U19AI111143-05S1